Yasons Chemex Care IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Chemical sector. Fedex Securities Private is the merchant banker of Yasons Chemex Care IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 20th January 2023.
Yasons Chemex Care IPO open date is 24th July 2023 and close date is 26th July 2023. IPO Allotment Date is 31st July 2023 and Listing date is 3rd August 2023.Yasons Chemex Care IPO size is Rs 20.57 Cr. crores with IPO price of Rs 40.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Fedex Securities Private Limited is the book-running lead manager of the Yasons Chemex Care IPO. Kfin Technologies Limited is the Registrar and Market Maker is Nikunj Stock Brokers Limited for Yasons Chemex Care IPO.
Yasons Chemex Care IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Yasons Chemex Care IPO, based in Ahmedabad, operates in the Chemical sector with a focus on Manufacturing of Dyes, Pigment Paste and FMCG Products. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Yasons Chemex Care IPO size is ₹ 20.57 Cr. Crores with fresh issue size of Rs 20.57 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Yasons Chemex Care IPO is expected to be 31st July 2023, after the finalization of basis of allotment. Investors can check Yasons Chemex Care IPO allotment status on the registrars website, Kfin Technologies Limited. Yasons Chemex Care IPO refund dates are 1st August 2023.
Yasons Chemex Care IPO is expected to be listed on 3rd August 2023.
The upper price band for the Yasons Chemex Care IPO is set at ₹ 40.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Yasons Chemex Care IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Yasons Chemex Care IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 26th July 2023. After submission, funds are blocked until the basis of allotment of Yasons Chemex Care IPO is finalised.
The merchant banker for Yasons Chemex Care IPO is Fedex Securities Private Limited . Fedex Securities Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Yasons Chemex Care IPO RHP for further details.
The registrar for Yasons Chemex Care IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Yasons Chemex Care IPO through their official website or helpline.
Yasons Chemex Care IPO was subscribed 59.60 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Yasons Chemex Care IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Yasons Chemex Care Financial Review Page
Merchant Banker(s) of Yasons Chemex Care IPO: Fedex Securities Private Limited
Yasons Chemex Care IPO subscription was 59.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Yasons Chemex Care IPO listed at a listing price of 33.60 against the offer price of 40.00.
The current market price of Yasons Chemex Care is 14.20.
Why Us?